STERIS plc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 40 trades in STERIS plc (NYSE: STE) since 2014, across 10 members, worth an estimated $442.52K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 24 buys against 15 sells, a modestly buy-led skew, with Democratic members responsible for 78% of the trades and Republican members 22%. The most recent disclosure shown was filed May 2026, and April Mcclain Delaney has filed the most STE transactions among those shown, with 7. Other recent filers include Ro Khanna and Gilbert Cisneros. One notable disclosed move was a purchase by Ro Khanna on January 29, 2026, down 19.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the STERIS plc (STE) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
STERIS plc congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | Apr 30, 2026 | 6 days | BUY | $1,001 - $15,000 | -3.08% | ||
![]() Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $1,001 - $15,000 | -4.19% | |
![]() Ro Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | SELL | $1,001 - $15,000 | -4.89% | |
| Apr 6, 2026 | Mar 16, 2026 | 21 days | BUY | $1,001 - $15,000 | -4.04% | ||
| Apr 6, 2026 | Mar 16, 2026 | 21 days | BUY | $1,001 - $15,000 | -4.04% | ||
![]() Gilbert Cisneros House | Mar 9, 2026 | Feb 10, 2026 | 27 days | BUY | $1,001 - $15,000 | -13.87% | |
![]() Gilbert Cisneros House | Mar 9, 2026 | Feb 10, 2026 | 27 days | BUY | $1,001 - $15,000 | -13.87% | |
| Mar 10, 2026 | Feb 6, 2026 | 32 days | BUY | $1,001 - $15,000 | -16.43% | ||
![]() Ro Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | -13.57% | |
![]() Ro Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | -19.46% |
STERIS plc (STE) congressional trading FAQ
Can members of Congress legally trade STERIS plc (STE) stock?
Yes. Members of Congress are permitted to trade individual stocks, including STERIS plc (STE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional STERIS plc (STE) trades public?
Yes. Every congressional trade in STERIS plc (STE) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded STERIS plc (STE)?
Members of Congress have disclosed 40 trades in STERIS plc (STE) worth $442.52K across 10 members, according to public STOCK Act filings.
Which members of Congress have traded STERIS plc (STE)?
Recent and active filers of STERIS plc (STE) disclosures include April Mcclain Delaney, Ro Khanna, Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade STERIS plc (STE) more?
Across disclosed STERIS plc (STE) trades, 78% were by Democrats and 23% by Republicans, led by Democrats (78%).
What is the most recent congressional STERIS plc (STE) trade?
The most recent disclosed STERIS plc (STE) trade was a purchase by April Mcclain Delaney, filed May 5, 2026.
Browse all stocks Congress tradesCongressional trading overviewSTERIS plc (STE) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.


